Bolei Dai
Impact in
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Phagocytosis and Immune Regulation
-
- Nanoparticle-Based Drug Delivery
Papers in
-
- Immunotherapy and Immune Responses 4
- Phagocytosis and Immune Regulation 3
- interferon and immune responses 1
-
- Ferroptosis and cancer prognosis 3
- Co-authors
- Zhihong Zhang (7 shared papers)Qingming Luo (4 shared papers)Xiang Min Yu (2 shared papers)Guoqiang Xu (2 shared papers)Yanfeng Dai (1 shared paper)Yuan Qian (1 shared paper)Lisen Lu (1 shared paper)Sha Qiao (1 shared paper)
- Journals
- Theranostics (3 papers)ACS Nano (2 papers)Antioxidants (1 paper)Nanophotonics (1 paper)Nature Communications (1 paper)
- Partner nations
- China
In The Last Decade
Bolei Dai
11 papers receiving 541 citations
Peers
Comparison fields: 5 of 58
- Immunology 277
- Biomaterials 75
- Biomedical Engineering 225
- Oncology 102
- Hepatology 26
Countries citing papers authored by Bolei Dai
This map shows the geographic impact of Bolei Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bolei Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bolei Dai more than expected).
Fields of papers citing papers by Bolei Dai
This network shows the impact of papers produced by Bolei Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bolei Dai. The network helps show where Bolei Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Bolei Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 313 | |
| 2 | 2019 | 130 | |
| 3 | 2019 | 21 | |
| 4 | 2021 | 18 | |
| 5 | 2022 | 16 | |
| 6 | 2020 | 12 | |
| 7 | 2024 | 11 | |
| 8 | 2024 | 8 | |
| 9 | 2024 | 7 | |
| 10 | 2024 | 6 | |
| 11 | 2023 | 4 |
About Bolei Dai
Bolei Dai is a scholar working on Immunology, Pulmonary and Respiratory Medicine, Cancer Research, Biophysics and Microbiology, having authored 11 papers that have together received 546 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Ferroptosis and cancer prognosis (3 papers), Photoacoustic and Ultrasonic Imaging (3 papers), Phagocytosis and Immune Regulation (3 papers), RNA modifications and cancer (2 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer Mechanisms and Therapy (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Immunology (277 citations), Biomaterials (75 citations), Biomedical Engineering (225 citations), Oncology (102 citations) and Hepatology (26 citations). Bolei Dai has collaborated with scholars based in China. Frequent co-authors include Zhihong Zhang, Qingming Luo, Xiang Min Yu, Guoqiang Xu, Yanfeng Dai, Yuan Qian, Lisen Lu, Sha Qiao, Jianqiao Liu and Guanxin Shen. Their work appears in journals such as Theranostics, ACS Nano, Antioxidants, Nanophotonics and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.